Click for best price
Idiopathic Pulmonary Fibrosis Market Size, Share 2023
| Market size in 2022 |
US$ 1781.8 million
|
Forecast Market size by 2029 |
US$ 3276.3 million
|
| Growth Rate |
CAGR of 9.1% |
Number of Pages |
64 Pages |
Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen.
This report aims to provide a comprehensive presentation of the global market for Idiopathic Pulmonary Fibrosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Idiopathic Pulmonary Fibrosis. This report contains market size and forecasts of Idiopathic Pulmonary Fibrosis in global, including the following market information:
Global Idiopathic Pulmonary Fibrosis Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Idiopathic Pulmonary Fibrosis market was valued at US$ 1781.8 million in 2022 and is projected to reach US$ 3276.3 million by 2029, at a CAGR of 9.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
An increase in the incidence and prevalence of fibrotic diseases is the primary driver for the growth of this market. Idiopathic pulmonary fibrosis most commonly affects middle-aged to older adults and is characterized by the scarring of lung tissues. In older people, these scars tend to build up and affect the normal functioning of lungs. Thus, an increase in aging population leads to increased prevalence of the disease, which in turn results in market growth during the predicted period.
We surveyed the Idiopathic Pulmonary Fibrosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Idiopathic Pulmonary Fibrosis Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Idiopathic Pulmonary Fibrosis Market Segment Percentages, by Type, 2022 (%)
Systemic Corticosteroids
Immunosuppressant Drugs
Tyrosine Kinase Inhibitors
Antifibrotic Agents
Global Idiopathic Pulmonary Fibrosis Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Idiopathic Pulmonary Fibrosis Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Ambulatory Surgical Centers
Academic and Research Organizations
Global Idiopathic Pulmonary Fibrosis Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Idiopathic Pulmonary Fibrosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Idiopathic Pulmonary Fibrosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Idiopathic Pulmonary Fibrosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
MediciNova
Boehringer Ingelheim
F. Hoffmann-La Roche
FibroGen
Promedior
Merck
Galapagos
Prometic Life Sciences
Cipla
Outline of Major Chapters:
Chapter 1: Introduces the definition of Idiopathic Pulmonary Fibrosis, market overview.
Chapter 2: Global Idiopathic Pulmonary Fibrosis market size in revenue.
Chapter 3: Detailed analysis of Idiopathic Pulmonary Fibrosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Idiopathic Pulmonary Fibrosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Idiopathic Pulmonary Fibrosis Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 1781.8 million
|
| Forecast Market size by 2029 |
US$ 3276.3 million
|
| Growth Rate |
CAGR of 9.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Idiopathic Pulmonary Fibrosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Idiopathic Pulmonary Fibrosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Idiopathic Pulmonary Fibrosis Overall Market Size
2.1 Global Idiopathic Pulmonary Fibrosis Market Size: 2022 VS 2029
2.2 Global Idiopathic Pulmonary Fibrosis Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Idiopathic Pulmonary Fibrosis Players in Global Market
3.2 Top Global Idiopathic Pulmonary Fibrosis Companies Ranked by Revenue
3.3 Global Idiopathic Pulmonary Fibrosis Revenue by Companies
3.4 Top 3 and Top 5 Idiopathic Pulmonary Fibrosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Idiopathic Pulmonary Fibrosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Idiopathic Pulmonary Fibrosis Players in Global Market
3.6.1 List of Global Tier 1 Idiopathic Pulmonary Fibrosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Idiopathic Pulmonary Fibrosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Idiopathic Pulmonary Fibrosis Market Size Markets, 2022 & 2029
4.1.2 Systemic Corticosteroids
4.1.3 Immunosuppressant Drugs
4.1.4 Tyrosine Kinase Inhibitors
4.1.5 Antifibrotic Agents
4.2 By Type - Global Idiopathic Pulmonary Fibrosis Revenue & Forecasts
4.2.1 By Type - Global Idiopathic Pulmonary Fibrosis Revenue, 2018-2023
4.2.2 By Type - Global Idiopathic Pulmonary Fibrosis Revenue, 2024-2029
4.2.3 By Type - Global Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Idiopathic Pulmonary Fibrosis Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Academic and Research Organizations
5.2 By Application - Global Idiopathic Pulmonary Fibrosis Revenue & Forecasts
5.2.1 By Application - Global Idiopathic Pulmonary Fibrosis Revenue, 2018-2023
5.2.2 By Application - Global Idiopathic Pulmonary Fibrosis Revenue, 2024-2029
5.2.3 By Application - Global Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Idiopathic Pulmonary Fibrosis Market Size, 2022 & 2029
6.2 By Region - Global Idiopathic Pulmonary Fibrosis Revenue & Forecasts
6.2.1 By Region - Global Idiopathic Pulmonary Fibrosis Revenue, 2018-2023
6.2.2 By Region - Global Idiopathic Pulmonary Fibrosis Revenue, 2024-2029
6.2.3 By Region - Global Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Idiopathic Pulmonary Fibrosis Revenue, 2018-2029
6.3.2 US Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.3.3 Canada Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.3.4 Mexico Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Idiopathic Pulmonary Fibrosis Revenue, 2018-2029
6.4.2 Germany Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.4.3 France Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.4.4 U.K. Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.4.5 Italy Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.4.6 Russia Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.4.7 Nordic Countries Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.4.8 Benelux Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Idiopathic Pulmonary Fibrosis Revenue, 2018-2029
6.5.2 China Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.5.3 Japan Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.5.4 South Korea Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.5.5 Southeast Asia Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.5.6 India Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Idiopathic Pulmonary Fibrosis Revenue, 2018-2029
6.6.2 Brazil Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.6.3 Argentina Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Idiopathic Pulmonary Fibrosis Revenue, 2018-2029
6.7.2 Turkey Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.7.3 Israel Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.7.4 Saudi Arabia Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
6.7.5 UAE Idiopathic Pulmonary Fibrosis Market Size, 2018-2029
7 Idiopathic Pulmonary Fibrosis Companies Profiles
7.1 MediciNova
7.1.1 MediciNova Company Summary
7.1.2 MediciNova Business Overview
7.1.3 MediciNova Idiopathic Pulmonary Fibrosis Major Product Offerings
7.1.4 MediciNova Idiopathic Pulmonary Fibrosis Revenue in Global Market (2018-2023)
7.1.5 MediciNova Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Major Product Offerings
7.2.4 Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Revenue in Global Market (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 F. Hoffmann-La Roche
7.3.1 F. Hoffmann-La Roche Company Summary
7.3.2 F. Hoffmann-La Roche Business Overview
7.3.3 F. Hoffmann-La Roche Idiopathic Pulmonary Fibrosis Major Product Offerings
7.3.4 F. Hoffmann-La Roche Idiopathic Pulmonary Fibrosis Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann-La Roche Key News & Latest Developments
7.4 FibroGen
7.4.1 FibroGen Company Summary
7.4.2 FibroGen Business Overview
7.4.3 FibroGen Idiopathic Pulmonary Fibrosis Major Product Offerings
7.4.4 FibroGen Idiopathic Pulmonary Fibrosis Revenue in Global Market (2018-2023)
7.4.5 FibroGen Key News & Latest Developments
7.5 Promedior
7.5.1 Promedior Company Summary
7.5.2 Promedior Business Overview
7.5.3 Promedior Idiopathic Pulmonary Fibrosis Major Product Offerings
7.5.4 Promedior Idiopathic Pulmonary Fibrosis Revenue in Global Market (2018-2023)
7.5.5 Promedior Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Idiopathic Pulmonary Fibrosis Major Product Offerings
7.6.4 Merck Idiopathic Pulmonary Fibrosis Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Galapagos
7.7.1 Galapagos Company Summary
7.7.2 Galapagos Business Overview
7.7.3 Galapagos Idiopathic Pulmonary Fibrosis Major Product Offerings
7.7.4 Galapagos Idiopathic Pulmonary Fibrosis Revenue in Global Market (2018-2023)
7.7.5 Galapagos Key News & Latest Developments
7.8 Prometic Life Sciences
7.8.1 Prometic Life Sciences Company Summary
7.8.2 Prometic Life Sciences Business Overview
7.8.3 Prometic Life Sciences Idiopathic Pulmonary Fibrosis Major Product Offerings
7.8.4 Prometic Life Sciences Idiopathic Pulmonary Fibrosis Revenue in Global Market (2018-2023)
7.8.5 Prometic Life Sciences Key News & Latest Developments
7.9 Cipla
7.9.1 Cipla Company Summary
7.9.2 Cipla Business Overview
7.9.3 Cipla Idiopathic Pulmonary Fibrosis Major Product Offerings
7.9.4 Cipla Idiopathic Pulmonary Fibrosis Revenue in Global Market (2018-2023)
7.9.5 Cipla Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Idiopathic Pulmonary Fibrosis Market Opportunities & Trends in Global Market
Table 2. Idiopathic Pulmonary Fibrosis Market Drivers in Global Market
Table 3. Idiopathic Pulmonary Fibrosis Market Restraints in Global Market
Table 4. Key Players of Idiopathic Pulmonary Fibrosis in Global Market
Table 5. Top Idiopathic Pulmonary Fibrosis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Idiopathic Pulmonary Fibrosis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Idiopathic Pulmonary Fibrosis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Idiopathic Pulmonary Fibrosis Product Type
Table 9. List of Global Tier 1 Idiopathic Pulmonary Fibrosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Idiopathic Pulmonary Fibrosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Idiopathic Pulmonary Fibrosis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Idiopathic Pulmonary Fibrosis Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Idiopathic Pulmonary Fibrosis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Idiopathic Pulmonary Fibrosis Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Idiopathic Pulmonary Fibrosis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Idiopathic Pulmonary Fibrosis Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2024-2029
Table 30. MediciNova Company Summary
Table 31. MediciNova Idiopathic Pulmonary Fibrosis Product Offerings
Table 32. MediciNova Idiopathic Pulmonary Fibrosis Revenue (US$, Mn) & (2018-2023)
Table 33. MediciNova Key News & Latest Developments
Table 34. Boehringer Ingelheim Company Summary
Table 35. Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Product Offerings
Table 36. Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Revenue (US$, Mn) & (2018-2023)
Table 37. Boehringer Ingelheim Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Company Summary
Table 39. F. Hoffmann-La Roche Idiopathic Pulmonary Fibrosis Product Offerings
Table 40. F. Hoffmann-La Roche Idiopathic Pulmonary Fibrosis Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffmann-La Roche Key News & Latest Developments
Table 42. FibroGen Company Summary
Table 43. FibroGen Idiopathic Pulmonary Fibrosis Product Offerings
Table 44. FibroGen Idiopathic Pulmonary Fibrosis Revenue (US$, Mn) & (2018-2023)
Table 45. FibroGen Key News & Latest Developments
Table 46. Promedior Company Summary
Table 47. Promedior Idiopathic Pulmonary Fibrosis Product Offerings
Table 48. Promedior Idiopathic Pulmonary Fibrosis Revenue (US$, Mn) & (2018-2023)
Table 49. Promedior Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Idiopathic Pulmonary Fibrosis Product Offerings
Table 52. Merck Idiopathic Pulmonary Fibrosis Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Galapagos Company Summary
Table 55. Galapagos Idiopathic Pulmonary Fibrosis Product Offerings
Table 56. Galapagos Idiopathic Pulmonary Fibrosis Revenue (US$, Mn) & (2018-2023)
Table 57. Galapagos Key News & Latest Developments
Table 58. Prometic Life Sciences Company Summary
Table 59. Prometic Life Sciences Idiopathic Pulmonary Fibrosis Product Offerings
Table 60. Prometic Life Sciences Idiopathic Pulmonary Fibrosis Revenue (US$, Mn) & (2018-2023)
Table 61. Prometic Life Sciences Key News & Latest Developments
Table 62. Cipla Company Summary
Table 63. Cipla Idiopathic Pulmonary Fibrosis Product Offerings
Table 64. Cipla Idiopathic Pulmonary Fibrosis Revenue (US$, Mn) & (2018-2023)
Table 65. Cipla Key News & Latest Developments
List of Figures
Figure 1. Idiopathic Pulmonary Fibrosis Segment by Type in 2022
Figure 2. Idiopathic Pulmonary Fibrosis Segment by Application in 2022
Figure 3. Global Idiopathic Pulmonary Fibrosis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Idiopathic Pulmonary Fibrosis Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Idiopathic Pulmonary Fibrosis Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Idiopathic Pulmonary Fibrosis Revenue in 2022
Figure 8. By Type - Global Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 9. By Application - Global Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 10. By Type - Global Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 12. By Application - Global Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 14. By Region - Global Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 15. By Country - North America Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 16. US Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 20. Germany Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 21. France Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 28. China Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 32. India Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 34. Brazil Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Idiopathic Pulmonary Fibrosis Revenue Market Share, 2018-2029
Figure 37. Turkey Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Idiopathic Pulmonary Fibrosis Revenue, (US$, Mn), 2018-2029
Figure 41. MediciNova Idiopathic Pulmonary Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffmann-La Roche Idiopathic Pulmonary Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. FibroGen Idiopathic Pulmonary Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Promedior Idiopathic Pulmonary Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Idiopathic Pulmonary Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Galapagos Idiopathic Pulmonary Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Prometic Life Sciences Idiopathic Pulmonary Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cipla Idiopathic Pulmonary Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
